10-Q Filing

CVS HEALTH CORP CIK: 64803 Q3 2025

Filing Information

Form Type	10-Q
Accession Number	`0000064803-25-000037`
Period End Date	20250930
Filing Date	20251029
Fiscal Year	2025
Fiscal Period	Q3
XBRL Instance	cvs-20250930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 212 Income Statement 186 Cash Flow Statement 198 Stockholders Equity 184 Comprehensive Income 88

Balance Sheet 212 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.59B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.59B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.10B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.10B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$2.41B	USD	Point-in-time
Investments	`ShortTermInvestments`	$2.41B	USD	Point-in-time
Investments	`ShortTermInvestments`	$2.13B	USD	Point-in-time
Investments	`ShortTermInvestments`	$2.13B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$36.47B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$36.47B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$43.86B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$43.86B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$18.11B	USD	Point-in-time
Inventories	`InventoryNet`	$18.11B	USD	Point-in-time
Inventories	`InventoryNet`	$18.96B	USD	Point-in-time
Inventories	`InventoryNet`	$18.96B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.08B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.08B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.06B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.06B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$68.64B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$68.64B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$77.11B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$77.11B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.78B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.78B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.79B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.79B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.26B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.26B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.27B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.27B	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$28.93B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$28.93B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$31.55B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$31.55B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$12.99B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$12.99B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$12.84B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$12.84B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	518.00M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	518.00M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	516.00M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	516.00M	shares	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$15.94B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$15.94B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$15.27B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$15.27B	USD	Point-in-time
Goodwill	`Goodwill`	$91.27B	USD	Point-in-time
Goodwill	`Goodwill`	$91.27B	USD	Point-in-time
Goodwill	`Goodwill`	$85.48B	USD	Point-in-time
Goodwill	`Goodwill`	$85.48B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$27.32B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$27.32B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$25.98B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$25.98B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$3.31B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$3.31B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$1.93B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$1.93B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.79B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.79B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.16B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.16B	USD	Point-in-time
Total assets	`Assets`	$253.22B	USD	Point-in-time
Total assets	`Assets`	$253.22B	USD	Point-in-time
Total assets	`Assets`	$255.33B	USD	Point-in-time
Total assets	`Assets`	$255.33B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$15.89B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$15.89B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$17.76B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$17.76B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$24.17B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$24.17B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$27.09B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$27.09B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$12.05B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$12.05B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$15.24B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$15.24B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$15.06B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$15.06B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$16.10B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$16.10B	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$20.81B	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$20.81B	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$23.41B	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$23.41B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.18B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.18B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.10B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.10B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.75B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.75B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.91B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.91B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$2.12B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$2.12B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$1.25B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$1.25B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$3.62B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$3.62B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$4.08B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$4.08B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$84.61B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$84.61B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$92.69B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$92.69B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$14.90B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$14.90B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$14.01B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$14.01B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$60.53B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$60.53B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$60.51B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$60.51B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.81B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.81B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.55B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.55B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.25B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.25B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.33B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.33B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.31B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.31B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$1.93B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$1.93B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$4.90B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$4.90B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$4.77B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$4.77B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$5.43B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$5.43B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$4.76B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$4.76B	USD	Point-in-time
Total liabilities	`Liabilities`	$177.49B	USD	Point-in-time
Total liabilities	`Liabilities`	$177.49B	USD	Point-in-time
Total liabilities	`Liabilities`	$182.22B	USD	Point-in-time
Total liabilities	`Liabilities`	$182.22B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,786 shares issued and 1,270 shares outstanding at September 30, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$49.66B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,786 shares issued and 1,270 shares outstanding at September 30, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$49.66B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,786 shares issued and 1,270 shares outstanding at September 30, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$50.18B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,786 shares issued and 1,270 shares outstanding at September 30, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$50.18B	USD	Point-in-time
Treasury stock, at cost: 516 and 518 shares at September 30, 2025 and December 31, 2024	`TreasuryStockCommonValue`	$36.82B	USD	Point-in-time
Treasury stock, at cost: 516 and 518 shares at September 30, 2025 and December 31, 2024	`TreasuryStockCommonValue`	$36.82B	USD	Point-in-time
Treasury stock, at cost: 516 and 518 shares at September 30, 2025 and December 31, 2024	`TreasuryStockCommonValue`	$36.78B	USD	Point-in-time
Treasury stock, at cost: 516 and 518 shares at September 30, 2025 and December 31, 2024	`TreasuryStockCommonValue`	$36.78B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$62.84B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$62.84B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$59.11B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$59.11B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-120.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-120.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$416.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$416.00M	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$75.56B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$75.56B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$72.93B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$72.93B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$170.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$170.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$182.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$182.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.64B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.64B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.15B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.15B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.11B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.11B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.11B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.11B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.73B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.73B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.11B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.11B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.55B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.55B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.11B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.11B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$253.22B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$253.22B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$255.33B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$255.33B	USD	Point-in-time

Income Statement 186 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$30.93B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$30.93B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$91.98B	USD	3 Qtrs
Premiums	`PremiumsEarnedNet`	$91.98B	USD	3 Qtrs
Premiums	`PremiumsEarnedNet`	$33.72B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$33.72B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$100.73B	USD	3 Qtrs
Premiums	`PremiumsEarnedNet`	$100.73B	USD	3 Qtrs
Net investment income	`NetInvestmentIncome`	$550.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$550.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$1.40B	USD	3 Qtrs
Net investment income	`NetInvestmentIncome`	$1.40B	USD	3 Qtrs
Net investment income	`NetInvestmentIncome`	$632.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$632.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$1.64B	USD	3 Qtrs
Net investment income	`NetInvestmentIncome`	$1.64B	USD	3 Qtrs
Total revenues	`Revenues`	$95.43B	USD	1 Quarter
Total revenues	`Revenues`	$95.43B	USD	1 Quarter
Total revenues	`Revenues`	$275.10B	USD	3 Qtrs
Total revenues	`Revenues`	$275.10B	USD	3 Qtrs
Total revenues	`Revenues`	$102.87B	USD	1 Quarter
Total revenues	`Revenues`	$102.87B	USD	1 Quarter
Total revenues	`Revenues`	$296.37B	USD	3 Qtrs
Total revenues	`Revenues`	$296.37B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$52.95B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$52.95B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$151.02B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$151.02B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$57.05B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$57.05B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$162.11B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$162.11B	USD	3 Qtrs
Health care costs	`PolicyholderBenefitsAndClaimsIncurredNet`	$29.92B	USD	1 Quarter
Health care costs	`PolicyholderBenefitsAndClaimsIncurredNet`	$29.92B	USD	1 Quarter
Health care costs	`PolicyholderBenefitsAndClaimsIncurredNet`	$85.58B	USD	3 Qtrs
Health care costs	`PolicyholderBenefitsAndClaimsIncurredNet`	$85.58B	USD	3 Qtrs
Health care costs	`PolicyholderBenefitsAndClaimsIncurredNet`	$32.02B	USD	1 Quarter
Health care costs	`PolicyholderBenefitsAndClaimsIncurredNet`	$32.02B	USD	1 Quarter
Health care costs	`PolicyholderBenefitsAndClaimsIncurredNet`	$92.47B	USD	3 Qtrs
Health care costs	`PolicyholderBenefitsAndClaimsIncurredNet`	$92.47B	USD	3 Qtrs
Operating expenses	`OtherCostAndExpenseOperating`	$10.56B	USD	1 Quarter
Operating expenses	`OtherCostAndExpenseOperating`	$10.56B	USD	1 Quarter
Operating expenses	`OtherCostAndExpenseOperating`	$31.18B	USD	3 Qtrs
Operating expenses	`OtherCostAndExpenseOperating`	$31.18B	USD	3 Qtrs
Operating expenses	`OtherCostAndExpenseOperating`	$11.29B	USD	1 Quarter
Operating expenses	`OtherCostAndExpenseOperating`	$11.29B	USD	1 Quarter
Operating expenses	`OtherCostAndExpenseOperating`	$33.52B	USD	3 Qtrs
Operating expenses	`OtherCostAndExpenseOperating`	$33.52B	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	$5.72B	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	$5.72B	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	$5.72B	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	$5.72B	USD	3 Qtrs
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	$1.17B	USD	1 Quarter
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	$1.17B	USD	1 Quarter
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	$1.17B	USD	3 Qtrs
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	$1.17B	USD	3 Qtrs
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	-	USD	1 Quarter
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	-	USD	1 Quarter
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	-	USD	3 Qtrs
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	-	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$94.60B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$94.60B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$268.95B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$268.95B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$106.08B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$106.08B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$293.83B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$293.83B	USD	3 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$832.00M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$832.00M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$6.15B	USD	3 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$6.15B	USD	3 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-3.21B	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-3.21B	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$2.55B	USD	3 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$2.55B	USD	3 Qtrs
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	-	USD	1 Quarter
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	-	USD	1 Quarter
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	-	USD	3 Qtrs
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	-	USD	3 Qtrs
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	$483.00M	USD	Point-in-time
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	$483.00M	USD	Point-in-time
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	$483.00M	USD	1 Quarter
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	$483.00M	USD	1 Quarter
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	$483.00M	USD	3 Qtrs
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	$483.00M	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$752.00M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$752.00M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$2.20B	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$2.20B	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$784.00M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$784.00M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$2.33B	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$2.33B	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$25.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$25.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$74.00M	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$74.00M	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$26.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$26.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$83.00M	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$83.00M	USD	3 Qtrs
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$105.00M	USD	1 Quarter
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$105.00M	USD	1 Quarter
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.02B	USD	3 Qtrs
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.02B	USD	3 Qtrs
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.48B	USD	1 Quarter
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.48B	USD	1 Quarter
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$782.00M	USD	3 Qtrs
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$782.00M	USD	3 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$34.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$34.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$1.06B	USD	3 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$1.06B	USD	3 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$508.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$508.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$1.98B	USD	3 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$1.98B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.12B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.12B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.77B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.77B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$71.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$71.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.96B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$2.96B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.01B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.01B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.99B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.99B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-1.20B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-1.20B	USD	3 Qtrs
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-16.00M	USD	1 Quarter
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-16.00M	USD	1 Quarter
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-7.00M	USD	3 Qtrs
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-7.00M	USD	3 Qtrs
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-15.00M	USD	1 Quarter
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-15.00M	USD	1 Quarter
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-20.00M	USD	3 Qtrs
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-20.00M	USD	3 Qtrs
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$87.00M	USD	1 Quarter
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$87.00M	USD	1 Quarter
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$2.97B	USD	3 Qtrs
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$2.97B	USD	3 Qtrs
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$-3.98B	USD	1 Quarter
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$-3.98B	USD	1 Quarter
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$-1.18B	USD	3 Qtrs
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$-1.18B	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.07	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.07	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.36	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.36	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-3.13	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-3.13	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.93	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.93	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.07	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.07	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.35	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.35	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-3.13	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-3.13	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.93	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.93	USD	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.26B	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.26B	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.26B	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.26B	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.27B	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.27B	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.27B	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.27B	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.26B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.26B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.26B	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.26B	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.27B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.27B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.27B	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.27B	shares	3 Qtrs

Cash Flow Statement 198 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$264.54B	USD	3 Qtrs
Cash receipts from customers	`ProceedsFromCustomers`	$264.54B	USD	3 Qtrs
Cash receipts from customers	`ProceedsFromCustomers`	$283.38B	USD	3 Qtrs
Cash receipts from customers	`ProceedsFromCustomers`	$283.38B	USD	3 Qtrs
Cash paid for inventory, prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$145.47B	USD	3 Qtrs
Cash paid for inventory, prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$145.47B	USD	3 Qtrs
Cash paid for inventory, prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$157.85B	USD	3 Qtrs
Cash paid for inventory, prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$157.85B	USD	3 Qtrs
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$80.36B	USD	3 Qtrs
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$80.36B	USD	3 Qtrs
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$88.77B	USD	3 Qtrs
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$88.77B	USD	3 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$28.93B	USD	3 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$28.93B	USD	3 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$27.31B	USD	3 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$27.31B	USD	3 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$1.29B	USD	3 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$1.29B	USD	3 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$1.49B	USD	3 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$1.49B	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$2.39B	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$2.39B	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$2.53B	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$2.53B	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$1.43B	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$1.43B	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$1.17B	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$1.17B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.25B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.25B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.25B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.25B	USD	3 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$7.63B	USD	3 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$7.63B	USD	3 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$9.64B	USD	3 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$9.64B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$12.68B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$12.68B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$11.04B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$11.04B	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.01B	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.01B	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.05B	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.05B	USD	3 Qtrs
Acquisitions	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$85.00M	USD	3 Qtrs
Acquisitions	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$85.00M	USD	3 Qtrs
Acquisitions	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$429.00M	USD	3 Qtrs
Acquisitions	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$429.00M	USD	3 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-75.00M	USD	3 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-75.00M	USD	3 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-9.00M	USD	3 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-9.00M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-7.07B	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-7.07B	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.87B	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.87B	USD	3 Qtrs
Commercial paper borrowings (repayments), net	`ProceedsFromRepaymentsOfCommercialPaper`	$600.00M	USD	3 Qtrs
Commercial paper borrowings (repayments), net	`ProceedsFromRepaymentsOfCommercialPaper`	$600.00M	USD	3 Qtrs
Commercial paper borrowings (repayments), net	`ProceedsFromRepaymentsOfCommercialPaper`	$-872.00M	USD	3 Qtrs
Commercial paper borrowings (repayments), net	`ProceedsFromRepaymentsOfCommercialPaper`	$-872.00M	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$4.96B	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$4.96B	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$3.97B	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$3.97B	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.71B	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.71B	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$3.61B	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$3.61B	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$3.02B	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$3.02B	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$2.54B	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$2.54B	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$2.55B	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$2.55B	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$342.00M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$342.00M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$308.00M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$308.00M	USD	3 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$181.00M	USD	3 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$181.00M	USD	3 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$145.00M	USD	3 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$145.00M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-22.00M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-22.00M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-7.00M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-7.00M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.57B	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.57B	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.91B	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.91B	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.39B	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.39B	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$468.00M	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$468.00M	USD	3 Qtrs
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.53B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.53B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.14B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.14B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.88B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.88B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.35B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.35B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.53B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.53B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.14B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.14B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.88B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.88B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.35B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.35B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$1.12B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.12B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.77B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.77B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$71.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$71.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.96B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$2.96B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.01B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.01B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.99B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.99B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-1.20B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-1.20B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.16B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.16B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.45B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.45B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.13B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.13B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.46B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.46B	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	$5.72B	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	$5.72B	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	$5.72B	USD	3 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	$5.72B	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$403.00M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$403.00M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$400.00M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$400.00M	USD	3 Qtrs
Loss on sale of subsidiary	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Loss on sale of subsidiary	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Loss on sale of subsidiary	`GainLossOnSaleOfBusiness`	$-236.00M	USD	3 Qtrs
Loss on sale of subsidiary	`GainLossOnSaleOfBusiness`	$-236.00M	USD	3 Qtrs
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	-	USD	1 Quarter
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	-	USD	1 Quarter
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	-	USD	3 Qtrs
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	-	USD	3 Qtrs
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	$483.00M	USD	Point-in-time
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	$483.00M	USD	Point-in-time
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	$483.00M	USD	1 Quarter
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	$483.00M	USD	1 Quarter
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	$483.00M	USD	3 Qtrs
Gain on deconsolidation of subsidiary	`DeconsolidationGainOrLossAmount`	$483.00M	USD	3 Qtrs
Restructuring charges (impairment of long-lived assets)	`RestructuringCostsAssetImpairmentCharges`	$840.00M	USD	3 Qtrs
Restructuring charges (impairment of long-lived assets)	`RestructuringCostsAssetImpairmentCharges`	$840.00M	USD	3 Qtrs
Restructuring charges (impairment of long-lived assets)	`RestructuringCostsAssetImpairmentCharges`	-	USD	3 Qtrs
Restructuring charges (impairment of long-lived assets)	`RestructuringCostsAssetImpairmentCharges`	-	USD	3 Qtrs
Deferred income taxes and other items	`DeferredIncomeTaxesAndOtherItems`	$-912.00M	USD	3 Qtrs
Deferred income taxes and other items	`DeferredIncomeTaxesAndOtherItems`	$-912.00M	USD	3 Qtrs
Deferred income taxes and other items	`DeferredIncomeTaxesAndOtherItems`	$-440.00M	USD	3 Qtrs
Deferred income taxes and other items	`DeferredIncomeTaxesAndOtherItems`	$-440.00M	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$986.00M	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$986.00M	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$7.54B	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$7.54B	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-355.00M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-355.00M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$982.00M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$982.00M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$850.00M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$850.00M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$588.00M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$588.00M	USD	3 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$2.17B	USD	3 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$2.17B	USD	3 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$5.05B	USD	3 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$5.05B	USD	3 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$2.88B	USD	3 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$2.88B	USD	3 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$734.00M	USD	3 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$734.00M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-3.06B	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-3.06B	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$2.87B	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$2.87B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.25B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.25B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.25B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.25B	USD	3 Qtrs

Stockholders Equity 184 line items

Line Item	Tag	Value	Unit	Period
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$2.00	USD	3 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$2.00	USD	3 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$2.00	USD	3 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$2.00	USD	3 Qtrs
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Treasury shares outstanding, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	518.00M	shares	Point-in-time
Treasury shares outstanding, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	518.00M	shares	Point-in-time
Treasury shares outstanding, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	516.00M	shares	Point-in-time
Treasury shares outstanding, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	516.00M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.64B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.64B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.15B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.15B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.11B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.11B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.11B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.11B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.73B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.73B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.11B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.11B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.55B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.55B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.11B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.11B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$1.12B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.12B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.77B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.77B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$71.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$71.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.96B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$2.96B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.01B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.01B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.99B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.99B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-1.20B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-1.20B	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-44.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-44.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$22.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$22.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$528.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$528.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$506.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$506.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$179.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$179.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$213.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$213.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$144.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$144.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$536.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$536.00M	USD	3 Qtrs
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$244.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$244.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$159.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$159.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$138.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$138.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$176.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$176.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$183.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$183.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$161.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$161.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$107.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$107.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$83.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$83.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$73.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$73.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$2.96B	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$2.96B	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$143.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$143.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$114.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$114.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$844.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$844.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$846.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$846.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$846.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$846.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$848.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$848.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$853.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$853.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$854.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$854.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-4.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-4.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$1.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$1.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-3.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-3.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$8.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$8.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-1.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-1.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$25.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$25.00M	USD	1 Quarter
Treasury shares outstanding, balance at end of period (in shares)	`TreasuryStockCommonShares`	518.00M	shares	Point-in-time
Treasury shares outstanding, balance at end of period (in shares)	`TreasuryStockCommonShares`	518.00M	shares	Point-in-time
Treasury shares outstanding, balance at end of period (in shares)	`TreasuryStockCommonShares`	516.00M	shares	Point-in-time
Treasury shares outstanding, balance at end of period (in shares)	`TreasuryStockCommonShares`	516.00M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.64B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.64B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.15B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.15B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.11B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.11B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.11B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.11B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.73B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.73B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.11B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.11B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.55B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.55B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.11B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.11B	USD	Point-in-time

Comprehensive Income 88 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$1.12B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.12B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.77B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.77B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$71.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$71.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.96B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$2.96B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.01B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.01B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.99B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.99B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-1.20B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-1.20B	USD	3 Qtrs
Net unrealized investment gains	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$679.00M	USD	1 Quarter
Net unrealized investment gains	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$679.00M	USD	1 Quarter
Net unrealized investment gains	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$544.00M	USD	3 Qtrs
Net unrealized investment gains	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$544.00M	USD	3 Qtrs
Net unrealized investment gains	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$192.00M	USD	1 Quarter
Net unrealized investment gains	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$192.00M	USD	1 Quarter
Net unrealized investment gains	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$595.00M	USD	3 Qtrs
Net unrealized investment gains	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$595.00M	USD	3 Qtrs
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$-147.00M	USD	1 Quarter
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$-147.00M	USD	1 Quarter
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$-26.00M	USD	3 Qtrs
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$-26.00M	USD	3 Qtrs
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$-50.00M	USD	1 Quarter
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$-50.00M	USD	1 Quarter
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$-60.00M	USD	3 Qtrs
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$-60.00M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$6.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$6.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$10.00M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$10.00M	USD	3 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-4.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-4.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-12.00M	USD	3 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-12.00M	USD	3 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-4.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-4.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-9.00M	USD	3 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-9.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-44.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-44.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$22.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$22.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$528.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$528.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$506.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$506.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$179.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$179.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$213.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$213.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$144.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$144.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$536.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$536.00M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$599.00M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$599.00M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.47B	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.47B	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.85B	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.85B	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-659.00M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-659.00M	USD	3 Qtrs
Comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-16.00M	USD	1 Quarter
Comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-16.00M	USD	1 Quarter
Comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-7.00M	USD	3 Qtrs
Comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-7.00M	USD	3 Qtrs
Comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-15.00M	USD	1 Quarter
Comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-15.00M	USD	1 Quarter
Comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-20.00M	USD	3 Qtrs
Comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-20.00M	USD	3 Qtrs
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$615.00M	USD	1 Quarter
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$615.00M	USD	1 Quarter
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$3.48B	USD	3 Qtrs
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$3.48B	USD	3 Qtrs
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$-3.83B	USD	1 Quarter
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$-3.83B	USD	1 Quarter
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$-639.00M	USD	3 Qtrs
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$-639.00M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.